Applied DNA Sciences (APDN) Revenue & Revenue Breakdown
Applied DNA Sciences Revenue Highlights
Latest Revenue (Y)
$13.37M
Latest Revenue (Q)
$797.52K
Main Segment (Y)
Clinical Laboratory Testing Services (Point-in-Time)
Main Geography (Y)
Americas
Applied DNA Sciences Revenue by Period
Applied DNA Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $13.37M | -26.43% |
| 2022-09-30 | $18.17M | 101.25% |
| 2021-09-30 | $9.03M | 367.40% |
| 2020-09-30 | $1.93M | -64.16% |
| 2019-09-30 | $5.39M | 38.06% |
| 2018-09-30 | $3.90M | -17.85% |
| 2017-09-30 | $4.75M | 13.49% |
| 2016-09-30 | $4.19M | -53.53% |
| 2015-09-30 | $9.01M | 231.05% |
| 2014-09-30 | $2.72M | 33.64% |
| 2013-09-30 | $2.04M | 9.79% |
| 2012-09-30 | $1.85M | 91.43% |
| 2011-09-30 | $968.85K | 86.37% |
| 2010-09-30 | $519.84K | 76.12% |
| 2009-09-30 | $295.16K | -66.19% |
| 2008-09-30 | $873.01K | 616.05% |
| 2007-09-30 | $121.92K | 545.08% |
| 2006-09-30 | $18.90K | 100.00% |
| 2005-09-30 | - | 100.00% |
| 2004-09-30 | - | 100.00% |
| 2003-09-30 | - | 100.00% |
| 2001-12-31 | - | 100.00% |
| 2000-12-31 | - | 100.00% |
| 1999-12-31 | - | 100.00% |
| 1998-12-31 | - | 100.00% |
| 1997-12-31 | - | - |
Applied DNA Sciences generated $13.37M in revenue during NA 2023, up -26.43% compared to the previous quarter, and up 342.46% compared to the same period a year ago.
Applied DNA Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $797.52K | -14.21% |
| 2024-03-31 | $929.63K | 4.32% |
| 2023-12-31 | $891.16K | 14.29% |
| 2023-09-30 | $779.74K | -73.27% |
| 2023-06-30 | $2.92M | -33.81% |
| 2023-03-31 | $4.41M | -16.25% |
| 2022-12-31 | $5.26M | 47.86% |
| 2022-09-30 | $3.56M | -17.16% |
| 2022-06-30 | $4.30M | -30.11% |
| 2022-03-31 | $6.15M | 47.57% |
| 2021-12-31 | $4.17M | 37.04% |
| 2021-09-30 | $3.04M | 78.77% |
| 2021-06-30 | $1.70M | -36.35% |
| 2021-03-31 | $2.67M | 65.30% |
| 2020-12-31 | $1.62M | 414.71% |
| 2020-09-30 | $313.99K | -27.24% |
| 2020-06-30 | $431.52K | -21.89% |
| 2020-03-31 | $552.47K | -12.79% |
| 2019-12-31 | $633.52K | -62.13% |
| 2019-09-30 | $1.67M | -18.54% |
| 2019-06-30 | $2.05M | 163.78% |
| 2019-03-31 | $778.47K | -11.97% |
| 2018-12-31 | $884.32K | -26.02% |
| 2018-09-30 | $1.20M | 17.61% |
| 2018-06-30 | $1.02M | -2.64% |
| 2018-03-31 | $1.04M | 61.18% |
| 2017-12-31 | $647.68K | -43.46% |
| 2017-09-30 | $1.15M | -36.27% |
| 2017-06-30 | $1.80M | 98.52% |
| 2017-03-31 | $905.37K | 0.26% |
| 2016-12-31 | $903.01K | -44.81% |
| 2016-09-30 | $1.64M | 150.59% |
| 2016-06-30 | $652.90K | 13.88% |
| 2016-03-31 | $573.32K | -56.70% |
| 2015-12-31 | $1.32M | -66.73% |
| 2015-09-30 | $3.98M | 75.52% |
| 2015-06-30 | $2.27M | 49.31% |
| 2015-03-31 | $1.52M | 22.30% |
| 2014-12-31 | $1.24M | 92.37% |
| 2014-09-30 | $645.53K | -23.26% |
| 2014-06-30 | $841.20K | 32.03% |
| 2014-03-31 | $637.15K | 6.66% |
| 2013-12-31 | $597.35K | -18.07% |
| 2013-09-30 | $729.11K | 13.07% |
| 2013-06-30 | $644.84K | 87.12% |
| 2013-03-31 | $344.61K | 8.48% |
| 2012-12-31 | $317.67K | 9.23% |
| 2012-09-30 | $290.81K | -44.98% |
| 2012-06-30 | $528.57K | 1.96% |
| 2012-03-31 | $518.40K | 0.29% |
| 2011-12-31 | $516.90K | 84.03% |
| 2011-09-30 | $280.88K | 22.28% |
| 2011-06-30 | $229.71K | 63.56% |
| 2011-03-31 | $140.44K | -55.81% |
| 2010-12-31 | $317.82K | 254.47% |
| 2010-09-30 | $89.66K | -47.32% |
| 2010-06-30 | $170.19K | -9.12% |
| 2010-03-31 | $187.28K | 157.55% |
| 2009-12-31 | $72.72K | 19.22% |
| 2009-09-30 | $60.99K | 166.05% |
| 2009-06-30 | $22.93K | -64.55% |
| 2009-03-31 | $64.67K | -55.88% |
| 2008-12-31 | $146.57K | -49.35% |
| 2008-09-30 | $289.42K | 14.53% |
| 2008-06-30 | $252.69K | - |
| 2008-03-31 | $252.69K | - |
Applied DNA Sciences generated $797.52K in revenue during Q3 2024, up -14.21% compared to the previous quarter, and up 18.09% compared to the same period a year ago.
Applied DNA Sciences Revenue Breakdown
Applied DNA Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Sep 23 | Sep 22 | Sep 21 | Sep 20 | Sep 19 |
|---|---|---|---|---|---|
| Supply Chain | $827.60K | $38.58K | $1.44M | - | - |
| Asset Marking | $311.81K | $400.49K | $587.01K | - | - |
| Clinical Laboratory Testing Services (Over-Time) | $3.54M | - | - | - | - |
| Clinical Laboratory Testing Services (Point-in-Time) | $7.61M | - | - | - | - |
| Large Scale DNA Production | $653.01K | - | - | - | - |
| Research and Development Services (Over-Time) | $421.58K | - | - | - | - |
| Supply chain | - | $887.06K | $1.00M | - | - |
| Asset marking | - | $534.59K | $458.41K | - | - |
| Clinical laboratory testing services (over-time) | - | $5.13M | - | - | - |
| Clinical laboratory testing services (point-in-time) | - | $10.40M | $4.79M | - | - |
| Research and development services (over-time) | - | $592.00K | $799.72K | - | - |
| Diagnostic kits | - | - | $1.97M | - | - |
| Research And Development Services | - | - | - | $1.13M | $2.98M |
| Clinical Laboratory Testing Services | - | - | - | $81.95K | - |
| Large Scale Dna Production | - | - | - | $281.97K | $388.01K |
Applied DNA Sciences's latest annual revenue breakdown by segment (product or service), as of Sep 23: Clinical Laboratory Testing Services (Point-in-Time) (56.95%), Clinical Laboratory Testing Services (Over-Time) (26.49%), Supply Chain (6.19%), Large Scale DNA Production (4.89%), Research and Development Services (Over-Time) (3.15%), and Asset Marking (2.33%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Large Scale DNA Production | $258.15K | - | $271.88K | $253.63K | $127.51K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supply Chain | $275.26K | $467.49K | $145.38K | $242.83K | $27.64K | $411.76K | $23.95K | $67.06K | $32.94K | $2.90K | $4.36K | $12.65K | $18.67K | $1.03M | $161.93K | - | - | - | - | - |
| Research and Development Services (Over-Time) | $65.20K | $77.53K | $72.00K | $135.62K | $87.91K | $126.06K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Marking | $9.44K | $9.44K | $39.03K | $92.31K | $97.34K | $83.13K | $113.72K | $140.17K | $151.76K | $97.23K | $83.53K | $110.70K | $108.57K | $117.98K | $140.56K | - | - | - | - | - |
| Clinical Laboratory Testing Services (Over-Time) | $324.58K | $324.58K | $509.11K | $653.38K | $938.08K | $1.44M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Clinical Laboratory Testing Services (Point-in-Time) | $6.44K | $12.12K | $14.22K | $1.52M | $3.00M | $3.07M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Clinical laboratory testing services (point-in-time) | - | - | - | - | - | - | $1.69M | $2.51M | $4.33M | $1.87M | $1.64M | - | - | - | - | - | - | - | - | - |
| Clinical laboratory testing services (over-time) | - | - | - | - | - | - | $1.26M | $1.39M | $1.16M | $1.33M | - | - | - | - | - | - | - | - | - | - |
| Asset marking | - | - | - | - | - | - | $154.56K | $127.08K | $141.66K | $105.52K | $72.25K | - | - | - | - | - | - | - | - | - |
| Supply chain | - | - | - | - | - | - | $316.81K | $43.24K | $115.46K | $411.55K | $879.30K | - | - | - | - | - | - | - | - | - |
| Research and development services (over-time) | - | - | - | - | - | - | $119.46K | $152.73K | $219.90K | $105.69K | $213.43K | - | - | - | - | - | - | - | - | - |
| Diagnostic test kits | - | - | - | - | - | - | - | - | $180.02K | $342.82K | - | - | - | - | - | - | - | - | - | - |
| Diagnostic kits | - | - | - | - | - | - | - | - | - | - | $384.91K | - | - | - | - | - | - | - | - | - |
| Clinical Laboratory Testing Services | - | - | - | - | - | - | - | - | - | - | - | $826.61K | $1.55M | $772.77K | - | - | - | - | - | - |
| Diagnostic Kits | - | - | - | - | - | - | - | - | - | - | - | $494.27K | $724.59K | $394.96K | - | - | - | - | - | - |
| Equipment Lease Services Overtime | - | - | - | - | - | - | - | - | - | - | - | $43.96K | $60.09K | - | - | - | - | - | - | - |
| Large Scale Dna Production | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.00 | - | $142.53K | $139.44K | $204.90K | $142.52K |
| Research And Development Services | - | - | - | - | - | - | - | - | - | - | - | $197.81K | $124.76K | $263.71K | $131.91K | $343.62K | $286.60K | $366.83K | $318.40K | $1.61M |
| Product And Authentication Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Applied DNA Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Clinical Laboratory Testing Services (Over-Time) (34.56%), Supply Chain (29.31%), Large Scale DNA Production (27.49%), Research and Development Services (Over-Time) (6.94%), Asset Marking (1.01%), and Clinical Laboratory Testing Services (Point-in-Time) (0.69%).
Applied DNA Sciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Sep 23 | Sep 22 | Sep 21 | Sep 20 | Sep 19 |
|---|---|---|---|---|---|
| Europe | $258.36K | $448.85K | $359.51K | $266.70K | $600.37K |
| Asia and other | $886.44K | $175.39K | $147.89K | - | - |
| Americas | $12.22M | $17.54M | - | - | - |
| United States | - | - | $8.52M | - | - |
| Asia And Other | - | - | - | $499.48K | $622.40K |
| U | - | - | - | $1.17M | $4.17M |
Applied DNA Sciences's latest annual revenue breakdown by geography, as of Sep 23: Americas (91.44%), Asia and other (6.63%), and Europe (1.93%).
Quarterly Revenue by Country
| Country | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|
| U | $393.49K | $2.68M | - | - | - | - | - | - |
| Asia And Other | $170.79K | $-1.12M | $1.36M | $221.75K | $166.44K | $52.77K | $213.14K | $433.72K |
| Europe | $69.24K | $110.30K | $117.71K | $221.69K | $150.67K | $205.45K | $228.41K | $378.83K |
| UNITED STATES | - | - | $580.25K | $335.03K | $567.22K | $937.14K | $574.80K | $231.39K |
Applied DNA Sciences's latest quarterly revenue breakdown by geography, as of Dec 19: U (62.11%), Asia And Other (26.96%), and Europe (10.93%).
Applied DNA Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| PSNL | Personalis | $73.48M | $19.52M |
| STIM | Neuronetics | $71.35M | $16.45M |
| TRIB | Trinity Biotech | $56.83M | $14.70M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $14.82M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| APDN | Applied DNA Sciences | $13.37M | $797.52K |
| ISPC | iSpecimen | $9.93M | $2.86M |
| OCX | OncoCyte | $1.50M | $104.00K |
| MYNZ | Mainz Biomed B.V. | $895.48K | $214.76K |
| SERA | Sera Prognostics | $306.00K | - |
APDN Revenue FAQ
What is Applied DNA Sciences’s yearly revenue?
Applied DNA Sciences's yearly revenue for 2023 was $13.37M, representing a decrease of -26.43% compared to 2022. The company's yearly revenue for 2022 was $18.17M, representing an increase of 101.25% compared to 2021. APDN's yearly revenue for 2021 was $9.03M, representing an increase of 367.40% compared to 2020.
What is Applied DNA Sciences’s quarterly revenue?
Applied DNA Sciences's quarterly revenue for Q3 2024 was $797.52K, a -14.21% decrease from the previous quarter (Q2 2024), and a -72.66% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $929.63K, a 4.32% increase from the previous quarter (Q1 2024), and a -78.91% decrease year-over-year (Q2 2023). APDN's quarterly revenue for Q1 2024 was $891.16K, a 14.29% increase from the previous quarter (Q4 2023), and a -83.07% decrease year-over-year (Q1 2023).
What is Applied DNA Sciences’s revenue growth rate?
Applied DNA Sciences's revenue growth rate for the last 3 years (2021-2023) was 48.07%, and for the last 5 years (2019-2023) was 148.05%.
What are Applied DNA Sciences’s revenue streams?
Applied DNA Sciences's revenue streams in p 23 are Supply Chain, Asset Marking, Clinical Laboratory Testing Services (Over-Time), Clinical Laboratory Testing Services (Point-in-Time), Large Scale DNA Production, and Research and Development Services (Over-Time). Supply Chain generated $827.6K in revenue, accounting 6.19% of the company's total revenue, up 2045.33% year-over-year. Asset Marking generated $311.81K in revenue, accounting 2.33% of the company's total revenue, down -22.14% year-over-year. Clinical Laboratory Testing Services (Over-Time) generated $3.54M in revenue, accounting 26.49% of the company's total revenue Clinical Laboratory Testing Services (Point-in-Time) generated $7.61M in revenue, accounting 56.95% of the company's total revenue Large Scale DNA Production generated $653.02K in revenue, accounting 4.89% of the company's total revenue Research and Development Services (Over-Time) generated $421.58K in revenue, accounting 3.15% of the company's total revenue
What is Applied DNA Sciences’s main source of revenue?
For the fiscal year ending Sep 23, the largest source of revenue of Applied DNA Sciences was Clinical Laboratory Testing Services (Point-in-Time). This segment made a revenue of $7.61M, representing 56.95% of the company's total revenue.